PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+1.98%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.69B
AUM Growth
+$7.69B
Cap. Flow
+$360M
Cap. Flow %
4.68%
Top 10 Hldgs %
39.16%
Holding
167
New
26
Increased
15
Reduced
34
Closed
16

Top Buys

1
NAUT icon
Nautilus Biotechnolgy
NAUT
$90M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
$84.7M
3
UTHR icon
United Therapeutics
UTHR
$79.3M
4
ZY
Zymergen Inc. Common Stock
ZY
$65.3M
5
IOVA icon
Iovance Biotherapeutics
IOVA
$60.1M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$46.6M
2
ALLO icon
Allogene Therapeutics
ALLO
$40.4M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
$39.9M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$36.4M
5
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$35M

Sector Composition

1 Healthcare 85.23%
2 Financials 0.27%
3 Industrials 0.17%
4 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRNX icon
26
Crinetics Pharmaceuticals
CRNX
$3.21B
$74.7M 0.97%
3,963,517
+304,136
+8% +$5.73M
RLAY icon
27
Relay Therapeutics
RLAY
$688M
$73.8M 0.96%
2,018,097
– –
BEAM icon
28
Beam Therapeutics
BEAM
$1.82B
$69.2M 0.9%
537,635
– –
ZY
29
DELISTED
Zymergen Inc. Common Stock
ZY
$65.3M 0.85%
+1,633,332
New +$65.3M
CHRS icon
30
Coherus Oncology, Inc. Common Stock
CHRS
$145M
$65M 0.84%
4,697,612
– –
ATNX
31
DELISTED
Athenex, Inc. Common Stock
ATNX
$62.5M 0.81%
13,532,467
– –
ESTA icon
32
Establishment Labs
ESTA
$1.12B
$61.2M 0.79%
700,408
-286,879
-29% -$25.1M
KDMN
33
DELISTED
Kadmon Holdings, Inc.
KDMN
$60.8M 0.79%
15,711,334
– –
KRON
34
DELISTED
Kronos Bio
KRON
$60.5M 0.79%
2,528,052
-252,045
-9% -$6.04M
QTNT
35
DELISTED
Quotient Limited Ordinary Shares
QTNT
$59M 0.77%
16,200,818
– –
MGNX icon
36
MacroGenics
MGNX
$119M
$57.7M 0.75%
2,148,060
– –
MDT icon
37
Medtronic
MDT
$117B
$55.9M 0.72%
+450,000
New +$55.9M
MORF
38
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$53.8M 0.7%
938,140
– –
SLDB icon
39
Solid Biosciences
SLDB
$443M
$49.1M 0.64%
13,412,552
– –
AVIR icon
40
Atea Pharmaceuticals
AVIR
$275M
$48.5M 0.63%
2,259,224
-850,000
-27% -$18.3M
CMAX
41
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$42.8M 0.56%
3,320,000
+3,300,000
+16,500% +$42.6M
DBVT
42
DBV Technologies
DBVT
$257M
$42M 0.55%
7,695,505
– –
APLS icon
43
Apellis Pharmaceuticals
APLS
$3.5B
$41.8M 0.54%
+661,162
New +$41.8M
VRCA icon
44
Verrica Pharmaceuticals
VRCA
$48.8M
$40.8M 0.53%
3,610,412
– –
RAIN
45
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$39.4M 0.51%
+2,537,019
New +$39.4M
TMCI icon
46
Treace Medical Concepts
TMCI
$452M
$38.6M 0.5%
+1,235,886
New +$38.6M
TARS icon
47
Tarsus Pharmaceuticals
TARS
$2.42B
$37.6M 0.49%
1,296,416
– –
AXSM icon
48
Axsome Therapeutics
AXSM
$6.03B
$37.4M 0.48%
+553,908
New +$37.4M
VERU icon
49
Veru
VERU
$49.4M
$35.9M 0.47%
4,451,342
– –
ATHA icon
50
Athira Pharma
ATHA
$15.3M
$35.1M 0.46%
3,425,916
– –
1
2
3 4 5